NASDAQ:IVTY - Invuity Stock Price, Price Target & More

$3.75 -0.05 (-1.32 %)
(As of 04/24/2018 04:00 PM ET)
Previous Close$3.80
Today's Range$3.65 - $3.80
52-Week Range$3.30 - $9.70
Volume96,268 shs
Average Volume243,293 shs
Market Capitalization$88.84 million
P/E Ratio-1.70
Dividend YieldN/A
Beta-0.07

About Invuity (NASDAQ:IVTY)

Invuity logoInvuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

Receive IVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for IVTY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:IVTY
CUSIPN/A
Phone415-655-2100

Debt

Debt-to-Equity Ratio-33.85%
Current Ratio2.55%
Quick Ratio2.04%

Price-To-Earnings

Trailing P/E Ratio-1.70
Forward P/E Ratio-2.05
P/E GrowthN/A

Sales & Book Value

Annual Sales$39.62 million
Price / Sales2.21
Cash FlowN/A
Price / CashN/A
Book Value($0.05) per share
Price / Book-75.00

Profitability

EPS (Most Recent Fiscal Year)($2.20)
Net Income$-39,910,000.00
Net Margins-100.75%
Return on Equity-380.14%
Return on Assets-74.74%

Miscellaneous

Employees161
Outstanding Shares23,380,000

How to Become a New Pot Stock Millionaire

Invuity (NASDAQ:IVTY) Frequently Asked Questions

What is Invuity's stock symbol?

Invuity trades on the NASDAQ under the ticker symbol "IVTY."

How were Invuity's earnings last quarter?

Invuity (NASDAQ:IVTY) announced its quarterly earnings results on Tuesday, February, 13th. The medical instruments supplier reported ($0.43) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.50) by $0.07. The medical instruments supplier had revenue of $11.23 million for the quarter, compared to analyst estimates of $11.84 million. Invuity had a negative net margin of 100.75% and a negative return on equity of 380.14%. View Invuity's Earnings History.

What price target have analysts set for IVTY?

4 brokers have issued twelve-month price objectives for Invuity's stock. Their forecasts range from $6.00 to $12.00. On average, they anticipate Invuity's stock price to reach $9.3333 in the next twelve months. View Analyst Ratings for Invuity.

What are Wall Street analysts saying about Invuity stock?

Here are some recent quotes from research analysts about Invuity stock:
  • 1. Northland Securities analysts commented, "We would be remiss in not expressing our disappointment, and are lowering our PT to $6." (2/14/2018)
  • 2. According to Zacks Investment Research, "Invuity, Inc. is a medical technology company. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System and Waveguide XT System. The Company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems. Invuity, Inc. is based in San Francisco, California. " (1/30/2018)

Who are some of Invuity's key competitors?

Who are Invuity's key executives?

Invuity's management team includes the folowing people:
  • Mr. Philip M. Sawyer, CEO, Pres & Director (Age 53)
  • Mr. James H. MacKaness, Chief Financial Officer (Age 54)
  • Mr. Scott D. Flora, Interim Pres, CEO & Director (Age 62)
  • Mr. Alex Vayser, Co-Founder and Chief Technology Officer (Age 50)
  • Mr. Douglas W. Heigel, Sr. VP of Operations (Age 57)

When did Invuity IPO?

(IVTY) raised $48 million in an initial public offering (IPO) on the week of June 15th 2015. The company issued 4,000,000 shares at $12.00 per share. Piper Jaffray, Leerink Partners and Stifel acted as the underwriters for the IPO and William Blair was co-manager.

Has Invuity been receiving favorable news coverage?

News articles about IVTY stock have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Invuity earned a media sentiment score of 0.24 on Accern's scale. They also gave headlines about the medical instruments supplier an impact score of 46.05 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Invuity?

Shares of IVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invuity's stock price today?

One share of IVTY stock can currently be purchased for approximately $3.75.

How big of a company is Invuity?

Invuity has a market capitalization of $88.84 million and generates $39.62 million in revenue each year. The medical instruments supplier earns $-39,910,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis. Invuity employs 161 workers across the globe.

How can I contact Invuity?

Invuity's mailing address is 444 DE HARO STREET, SAN FRANCISCO CA, 94107. The medical instruments supplier can be reached via phone at 415-655-2100 or via email at irdept[email protected]


MarketBeat Community Rating for Invuity (IVTY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  257
MarketBeat's community ratings are surveys of what our community members think about Invuity and other stocks. Vote "Outperform" if you believe IVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Invuity (NASDAQ:IVTY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Invuity in the last 12 months. Their average twelve-month price target is $9.3333, suggesting that the stock has a possible upside of 148.89%. The high price target for IVTY is $12.00 and the low price target for IVTY is $6.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.3333$9.3333$11.6667$11.00
Price Target Upside: 148.89% upside136.29% upside38.07% upside41.03% upside

Invuity (NASDAQ:IVTY) Consensus Price Target History

Price Target History for Invuity (NASDAQ:IVTY)

Invuity (NASDAQ:IVTY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/14/2018Northland SecuritiesReiterated RatingBuy$6.00MediumView Rating Details
11/10/2017Piper JaffrayReiterated RatingBuy$12.00N/AView Rating Details
5/23/2017William BlairReiterated RatingBuyLowView Rating Details
4/27/2017Stifel NicolausReiterated RatingBuy -> Buy$9.00 -> $10.00HighView Rating Details
9/19/2016Lake Street CapitalInitiated CoverageBuy$18.00 -> $18.00N/AView Rating Details
8/29/2016Craig HallumInitiated CoverageBuy$25.00N/AView Rating Details
6/23/2016Leerink SwannReiterated RatingBuy$15.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Invuity (NASDAQ:IVTY) Earnings History and Estimates Chart

Earnings by Quarter for Invuity (NASDAQ:IVTY)

Invuity (NASDAQ:IVTY) Earnings Estimates

2018 EPS Consensus Estimate: ($1.56)
2019 EPS Consensus Estimate: ($1.43)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183($0.55)($0.18)($0.39)
Q2 20183($0.48)($0.10)($0.33)
Q3 20182($0.43)($0.40)($0.42)
Q4 20182($0.52)($0.32)($0.42)
Q1 20191($0.40)($0.40)($0.40)
Q2 20191($0.37)($0.37)($0.37)
Q3 20191($0.34)($0.34)($0.34)
Q4 20191($0.32)($0.32)($0.32)

Invuity (NASDAQ IVTY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2018Q4 2017($0.50)($0.43)$11.84 million$11.23 millionViewListenView Earnings Details
11/7/2017Q3 2017($0.5570)($0.52)$9.87 million$9.60 millionViewN/AView Earnings Details
7/25/2017Q2 2017($0.54)($0.61)$10.30 million$9.77 millionViewN/AView Earnings Details
4/26/2017Q1 2017($0.61)($0.64)$8.71 million$9.02 millionViewN/AView Earnings Details
2/14/2017Q4 2016($0.5580)($0.56)$9.14 million$9.36 millionViewListenView Earnings Details
11/3/2016Q3($0.6180)($0.56)$9.29 million$8.48 millionViewListenView Earnings Details
7/19/2016Q2($0.8080)($0.76)$8.04 million$8.20 millionViewListenView Earnings Details
5/5/2016Q1($0.68)($0.90)$6.10 million$6.40 millionViewListenView Earnings Details
2/24/2016Q4($0.7150)($0.76)$5.77 million$6.25 millionViewListenView Earnings Details
11/10/2015Q315($0.96)($0.69)$5.05 million$5.60 millionViewListenView Earnings Details
8/11/2015Q215($0.75)($3.20)$4.55 million$4.70 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Invuity (NASDAQ:IVTY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Invuity (NASDAQ IVTY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 10.50%
Institutional Ownership Percentage: 46.72%
Insider Trading History for Invuity (NASDAQ:IVTY)
Institutional Ownership by Quarter for Invuity (NASDAQ:IVTY)

Invuity (NASDAQ IVTY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2018Andrew SaleVPBuy8,848$3.90$34,507.2028,793View SEC Filing  
3/16/2018Gregory T LucierDirectorBuy64,158$3.90$250,216.20117,204View SEC Filing  
3/16/2018Marcia FishInsiderBuy2,528$3.90$9,859.2011,228View SEC Filing  
3/16/2018Scott D FloraCEOBuy25,281$3.90$98,595.9077,203View SEC Filing  
5/18/2017Eric W RobertsDirectorBuy6,500$7.07$45,955.00106,029View SEC Filing  
5/15/2017Eric W RobertsDirectorBuy5,000$7.88$39,400.00101,529View SEC Filing  
5/9/2017Eric W RobertsDirectorBuy2,000$8.80$17,600.0096,529View SEC Filing  
5/3/2017Reza ZadnoDirectorSell4,000$9.16$36,640.008,800View SEC Filing  
12/14/2016James E FlynnInsiderSell184,796$6.22$1,149,431.12View SEC Filing  
11/8/2016James H MackanessCFOBuy1,700$5.75$9,775.003,700View SEC Filing  
10/17/2016Eric W RobertsDirectorSell1,000$12.08$12,080.0069,945View SEC Filing  
10/6/2016Philip M SawyerInsiderSell900$13.01$11,709.00900View SEC Filing  
10/6/2016Robert GerberichVPSell1,500$12.72$19,080.001,500View SEC Filing  
10/3/2016Alex VayserInsiderSell3,000$13.18$39,540.00168,407View SEC Filing  
9/22/2016Eric W RobertsDirectorSell2,201$14.00$30,814.0069,945View SEC Filing  
9/15/2016Eric W RobertsDirectorSell5,000$13.47$67,350.0069,945View SEC Filing  
9/2/2016Eric W RobertsDirectorSell26,839$14.00$375,746.0069,945View SEC Filing  
9/1/2016Alex VayserInsiderSell7,000$14.00$98,000.00174,702View SEC Filing  
8/24/2016Alex VayserInsiderSell9,000$12.78$115,020.00188,702View SEC Filing  
8/24/2016Robert GerberichVPSell10,500$12.53$131,565.0010,500View SEC Filing  
8/23/2016Eric W RobertsDirectorSell5,000$12.00$60,000.0069,945View SEC Filing  
7/21/2016Alex VayserInsiderSell12,000$12.00$144,000.00190,702View SEC Filing  
7/21/2016Eric W RobertsDirectorSell42,000$12.00$504,000.0069,945View SEC Filing  
6/10/2016Gregory T LucierDirectorBuy8,442$7.56$63,821.5222,261View SEC Filing  
6/7/2016Gregory T LucierDirectorBuy5,601$7.00$39,207.0013,819View SEC Filing  
6/6/2016Gregory T LucierDirectorBuy26,728$6.90$184,423.2026,728View SEC Filing  
5/18/2016James H MackanessCFOBuy2,000$5.08$10,160.002,000View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Invuity (NASDAQ IVTY) News Headlines

Source:
DateHeadline
Invuity Announces 2018 First Quarter Financial Results and Conference Call DateInvuity Announces 2018 First Quarter Financial Results and Conference Call Date
finance.yahoo.com - April 19 at 4:32 PM
Critical Comparison: Invuity (IVTY) vs. Valeritas (VLRX)Critical Comparison: Invuity (IVTY) vs. Valeritas (VLRX)
www.americanbankingnews.com - April 18 at 8:50 AM
Contrasting Haemonetics (HAE) & Invuity (IVTY)Contrasting Haemonetics (HAE) & Invuity (IVTY)
www.americanbankingnews.com - April 16 at 7:17 AM
Invuitys (IVTY) "Buy" Rating Reaffirmed at Piper JaffrayInvuity's (IVTY) "Buy" Rating Reaffirmed at Piper Jaffray
www.americanbankingnews.com - April 15 at 11:42 PM
Invuity (IVTY) Given Consensus Rating of "Buy" by AnalystsInvuity (IVTY) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - April 15 at 9:51 AM
$9.58 Million in Sales Expected for Invuity (IVTY) This Quarter$9.58 Million in Sales Expected for Invuity (IVTY) This Quarter
www.americanbankingnews.com - April 11 at 1:47 AM
 Analysts Anticipate Invuity (IVTY) Will Post Earnings of -$0.52 Per Share Analysts Anticipate Invuity (IVTY) Will Post Earnings of -$0.52 Per Share
www.americanbankingnews.com - April 9 at 9:18 PM
Invuity (IVTY) Rating Increased to Hold at Zacks Investment ResearchInvuity (IVTY) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - April 7 at 11:36 PM
ValuEngine Lowers Invuity (IVTY) to Strong SellValuEngine Lowers Invuity (IVTY) to Strong Sell
www.americanbankingnews.com - April 3 at 1:22 PM
Edited Transcript of IVTY earnings conference call or presentation 13-Feb-18 10:00pm GMTEdited Transcript of IVTY earnings conference call or presentation 13-Feb-18 10:00pm GMT
finance.yahoo.com - April 1 at 9:46 AM
Invuity (IVTY) & The Competition Critical ReviewInvuity (IVTY) & The Competition Critical Review
www.americanbankingnews.com - March 30 at 3:12 PM
Invuity (IVTY) Rating Lowered to Sell at Zacks Investment ResearchInvuity (IVTY) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 29 at 7:58 PM
Invuity (IVTY) Downgraded by Zacks Investment ResearchInvuity (IVTY) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 26 at 4:18 PM
Zacks: Brokerages Anticipate Invuity (IVTY) Will Announce Quarterly Sales of $9.58 MillionZacks: Brokerages Anticipate Invuity (IVTY) Will Announce Quarterly Sales of $9.58 Million
www.americanbankingnews.com - March 25 at 2:00 AM
Invuity (IVTY) Receives Consensus Recommendation of "Buy" from BrokeragesInvuity (IVTY) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 21 at 10:10 AM
Contrasting Invuity (IVTY) & Its PeersContrasting Invuity (IVTY) & Its Peers
www.americanbankingnews.com - March 20 at 3:19 AM
Invuity (IVTY) VP Purchases $34,507.20 in StockInvuity (IVTY) VP Purchases $34,507.20 in Stock
www.americanbankingnews.com - March 19 at 10:28 PM
Scott D. Flora Buys 25,281 Shares of Invuity (IVTY) StockScott D. Flora Buys 25,281 Shares of Invuity (IVTY) Stock
www.americanbankingnews.com - March 19 at 10:12 PM
Insider Buying: Invuity (IVTY) Director Acquires 64,158 Shares of StockInsider Buying: Invuity (IVTY) Director Acquires 64,158 Shares of Stock
www.americanbankingnews.com - March 19 at 10:10 PM
Invuity, Inc. (IVTY) Prices Public Offering of 6.2M Common Stock at $3.50/ShareInvuity, Inc. (IVTY) Prices Public Offering of 6.2M Common Stock at $3.50/Share
www.streetinsider.com - March 15 at 4:48 PM
BRIEF-Invuity Announces Proposed Public Offering Of Common StockBRIEF-Invuity Announces Proposed Public Offering Of Common Stock
www.reuters.com - March 15 at 4:48 PM
Invuity Announces Pricing of Public Offering of Common StockInvuity Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - March 15 at 4:48 PM
Invuity Announces Proposed Public Offering of Common StockInvuity Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 14 at 5:31 PM
Invuity, Inc. (IVTY) Expected to Announce Quarterly Sales of $9.58 MillionInvuity, Inc. (IVTY) Expected to Announce Quarterly Sales of $9.58 Million
www.americanbankingnews.com - March 8 at 4:08 AM
 Analysts Anticipate Invuity, Inc. (IVTY) Will Announce Earnings of -$0.51 Per Share Analysts Anticipate Invuity, Inc. (IVTY) Will Announce Earnings of -$0.51 Per Share
www.americanbankingnews.com - March 6 at 5:08 PM
Invuity Announces Changes to Executive Leadership TeamInvuity Announces Changes to Executive Leadership Team
finance.yahoo.com - February 28 at 9:32 AM
Invuity, Inc. (IVTY) Receives Consensus Recommendation of "Buy" from AnalystsInvuity, Inc. (IVTY) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 24 at 9:54 AM
$9.58 Million in Sales Expected for Invuity, Inc. (IVTY) This Quarter$9.58 Million in Sales Expected for Invuity, Inc. (IVTY) This Quarter
www.americanbankingnews.com - February 19 at 2:06 AM
Q1 2018 EPS Estimates for Invuity, Inc. (IVTY) Decreased by AnalystQ1 2018 EPS Estimates for Invuity, Inc. (IVTY) Decreased by Analyst
www.americanbankingnews.com - February 16 at 7:28 AM
Invuity, Inc. (IVTY) Forecasted to Post Q1 2018 Earnings of ($0.45) Per ShareInvuity, Inc. (IVTY) Forecasted to Post Q1 2018 Earnings of ($0.45) Per Share
www.americanbankingnews.com - February 16 at 7:28 AM
FY2019 Earnings Estimate for Invuity, Inc. Issued By William Blair (IVTY)FY2019 Earnings Estimate for Invuity, Inc. Issued By William Blair (IVTY)
www.americanbankingnews.com - February 15 at 3:10 PM
Invuity (IVTY) Releases  Earnings Results, Beats Estimates By $0.07 EPSInvuity (IVTY) Releases Earnings Results, Beats Estimates By $0.07 EPS
www.americanbankingnews.com - February 14 at 12:26 PM
Invuity (IVTY) Rating Reiterated by Northland SecuritiesInvuity (IVTY) Rating Reiterated by Northland Securities
www.americanbankingnews.com - February 14 at 12:10 PM
Invuity Inc. to Host Earnings CallInvuity Inc. to Host Earnings Call
finance.yahoo.com - February 13 at 4:33 PM
Invuity Announces Fourth Quarter and Full Year 2017 Financial ResultsInvuity Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - February 13 at 4:33 PM
Short Interest in Invuity, Inc. (IVTY) Decreases By 35.6%Short Interest in Invuity, Inc. (IVTY) Decreases By 35.6%
www.americanbankingnews.com - February 12 at 4:08 AM
Invuity (IVTY) to Release Earnings on MondayInvuity (IVTY) to Release Earnings on Monday
www.americanbankingnews.com - February 5 at 3:44 AM
Invuity Announces 2017 Fourth Quarter, Full Year Financial Results and Conference Call DateInvuity Announces 2017 Fourth Quarter, Full Year Financial Results and Conference Call Date
finance.yahoo.com - January 31 at 9:17 AM
Invuity, Inc. (IVTY) Receives Average Rating of "Buy" from BrokeragesInvuity, Inc. (IVTY) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 30 at 9:39 AM
Invuity (IVTY) Upgraded to "Buy" at Zacks Investment ResearchInvuity (IVTY) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - January 27 at 6:40 AM
 Analysts Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 Million Analysts Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 Million
www.americanbankingnews.com - January 17 at 7:16 PM
-$0.50 EPS Expected for Invuity, Inc. (IVTY) This Quarter-$0.50 EPS Expected for Invuity, Inc. (IVTY) This Quarter
www.americanbankingnews.com - January 15 at 3:30 AM
How Do Analysts See Invuity Inc (NASDAQ:IVTY) Performing Over The Couple Of Years?How Do Analysts See Invuity Inc (NASDAQ:IVTY) Performing Over The Couple Of Years?
finance.yahoo.com - January 7 at 1:45 PM
Invuity, Inc. (IVTY) Given Average Rating of "Buy" by BrokeragesInvuity, Inc. (IVTY) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 5 at 10:18 AM
Zacks: Brokerages Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 MillionZacks: Brokerages Anticipate Invuity, Inc. (IVTY) Will Post Quarterly Sales of $11.84 Million
www.americanbankingnews.com - December 31 at 12:52 PM
ETFs with exposure to Invuity, Inc. : December 27, 2017ETFs with exposure to Invuity, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 11:39 AM
Invuity, Inc. :IVTY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017Invuity, Inc. :IVTY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 12:27 PM
Are Invuity Inc’s (NASDAQ:IVTY) Interest Costs Too High?Are Invuity Inc’s (NASDAQ:IVTY) Interest Costs Too High?
finance.yahoo.com - December 15 at 11:47 AM
Invuity, Inc. (IVTY) Expected to Announce Quarterly Sales of $11.84 MillionInvuity, Inc. (IVTY) Expected to Announce Quarterly Sales of $11.84 Million
www.americanbankingnews.com - December 14 at 4:16 PM
Invuity, Inc. (IVTY) Given Consensus Recommendation of "Buy" by BrokeragesInvuity, Inc. (IVTY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - December 11 at 11:40 AM

SEC Filings

Invuity (NASDAQ:IVTY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Invuity (NASDAQ:IVTY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Invuity (NASDAQ IVTY) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.